IBYME   02675
INSTITUTO DE BIOLOGIA Y MEDICINA EXPERIMENTAL
Unidad Ejecutora - UE
artículos
Título:
Clinical relevance of galectin-1 in hematologic malignancies treated with non-myeloablative hemopoietic stem cell transplantation
Autor/es:
LUDVIGSEN, M.; KAMPER, P.; NIELSEN, B.; RABINOVICH, G.A.; PETRUSKEVICIUS, I.; SøRENSEN, B.S.; OESTGAARD, L.G.; BJERRE, M.; HJORTEBJERG, R.; VASE, M.; HONORé, B.; D'AMORE, F.A.
Revista:
BONE MARROW TRANSPLANTATION
Editorial:
NATURE PUBLISHING GROUP
Referencias:
Año: 2016 vol. 51 p. 1387 - 1390
ISSN:
0268-3369
Resumen:
Non-myeloablative hemopoietic stem cell transplantation (NM-HSCT) is often the only curative treatment option for patients with hematologic malignancies. However, the treatment is frequently complicated by significant morbidity and mortality, acute GvHD (aGvHD) and chronic GvHD (cGvHD) being among the major causes.